Codexis Inc. (CDXS) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Codexis Inc. (CDXS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

4.88

0.35 (7.73%)

At close: Jan 15, 2025, 3:59 PM

4.87

-0.31%

After-hours Jan 15, 2025, 04:00 PM EST

undefined% (undefined)

Bid	4.5
Market Cap	397.53M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.88
PE Ratio (ttm)	-5.55
Forward PE	n/a
Analyst	Buy

Ask	5.7
Volume	733,161
Avg. Volume (20D)	701,140
Open	4.72
Previous Close	4.53
Day's Range	4.63 - 4.94
52-Week Range	2.53 - 6.08
Beta	undefined

About CDXS

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, whi...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Apr 22, 2010

Employees 174

Stock Exchange NASDAQ

Ticker Symbol CDXS

Website https://www.codexis.com

Analyst Forecast

According to 2 analyst ratings, the average rating for CDXS stock is "Buy." The 12-month stock price forecast is $11, which is an increase of 125.18% from the latest price.

Buy 50.00%

Hold 50.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Codexis Inc. is scheduled to release its earnings on Feb 26, 2025, during market hours.
Analysts project revenue of $27.41M, reflecting a 3.20% YoY growth and earnings per share of -0.02, making a -80.00% decrease YoY.

Why Price Moved

2 months ago · Source

+11.46%

Codexis shares are trading higher after the compan... Unlock content with Pro Subscription

8 months ago · Source

+17.37%

Codexis shares are trading higher after the company reported better-than-expected Q1 financial results.

News

2 months ago · seekingalpha.com

Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript

2 months ago · zacks.com

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

Codexis (CDXS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.26 per share a year ago.